CA2889592A1 - Process for preparing bile acid derivatives - Google Patents

Process for preparing bile acid derivatives Download PDF

Info

Publication number
CA2889592A1
CA2889592A1 CA2889592A CA2889592A CA2889592A1 CA 2889592 A1 CA2889592 A1 CA 2889592A1 CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A CA2889592 A CA 2889592A CA 2889592 A1 CA2889592 A1 CA 2889592A1
Authority
CA
Canada
Prior art keywords
compound
formula
pharmaceutically acceptable
preparing
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2889592A
Other languages
English (en)
French (fr)
Inventor
Roberto Pellicciari
Antimo GIOIELLO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intercept Pharmaceuticals Inc
Original Assignee
Intercept Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intercept Pharmaceuticals Inc filed Critical Intercept Pharmaceuticals Inc
Publication of CA2889592A1 publication Critical patent/CA2889592A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J9/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
    • C07J9/005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane containing a carboxylic function directly attached or attached by a chain containing only carbon atoms to the cyclopenta[a]hydrophenanthrene skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2889592A 2012-10-26 2013-10-25 Process for preparing bile acid derivatives Abandoned CA2889592A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261718966P 2012-10-26 2012-10-26
US61/718,966 2012-10-26
PCT/US2013/066917 WO2014066819A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Publications (1)

Publication Number Publication Date
CA2889592A1 true CA2889592A1 (en) 2014-05-01

Family

ID=50545344

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2889592A Abandoned CA2889592A1 (en) 2012-10-26 2013-10-25 Process for preparing bile acid derivatives

Country Status (22)

Country Link
US (2) US9777038B2 (cg-RX-API-DMAC7.html)
EP (1) EP2912013B1 (cg-RX-API-DMAC7.html)
JP (1) JP6272888B2 (cg-RX-API-DMAC7.html)
KR (1) KR102068381B1 (cg-RX-API-DMAC7.html)
CN (2) CN105102425B (cg-RX-API-DMAC7.html)
AU (1) AU2013334122B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015009395A2 (cg-RX-API-DMAC7.html)
CA (1) CA2889592A1 (cg-RX-API-DMAC7.html)
CY (1) CY1119731T1 (cg-RX-API-DMAC7.html)
DK (1) DK2912013T3 (cg-RX-API-DMAC7.html)
ES (1) ES2655034T3 (cg-RX-API-DMAC7.html)
HK (1) HK1253301A1 (cg-RX-API-DMAC7.html)
HU (1) HUE036887T2 (cg-RX-API-DMAC7.html)
IL (1) IL238454B (cg-RX-API-DMAC7.html)
MX (1) MX361653B (cg-RX-API-DMAC7.html)
NO (1) NO2968302T3 (cg-RX-API-DMAC7.html)
NZ (2) NZ745013A (cg-RX-API-DMAC7.html)
PL (1) PL2912013T3 (cg-RX-API-DMAC7.html)
PT (1) PT2912013T (cg-RX-API-DMAC7.html)
SG (1) SG11201503247UA (cg-RX-API-DMAC7.html)
SM (1) SMT201700602T1 (cg-RX-API-DMAC7.html)
WO (1) WO2014066819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives
ES2938874T3 (es) 2014-05-29 2023-04-17 Bar Pharmaceuticals S R L Derivados de colano para su uso en el tratamiento y/o prevención de enfermedades mediadas por FXR y TGR5/GPBAR1
US20170327531A1 (en) 2014-11-19 2017-11-16 NZP UK Limited 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
CN107207559B (zh) 2014-11-19 2019-10-25 Nzp英国有限公司 作为制备类固醇fxr调节剂的中间体的6-烷基-7-羟基-4-烯-3-酮类固醇
JP6724004B2 (ja) 2014-11-19 2020-07-15 エヌゼットピー ユーケー リミテッド ステロイドFXRモジュレーター製造のための中間体としての5β−6−アルキル−7−ヒドロキシ−3−オンステロイド
CN107108688B (zh) 2014-11-19 2019-10-29 Nzp英国有限公司 作为制备类固醇FXR调节剂的中间体的6α-烷基-3,7-二酮类固醇
CN104672290B (zh) * 2015-01-05 2017-06-06 北京普禄德医药科技有限公司 一种用于预防或治疗fxr‑介导的疾病的药物及其制备方法和用途
TN2017000344A1 (en) 2015-02-06 2019-01-16 Intercept Pharmaceuticals Inc Pharmaceutical compositions for combination therapy
CN108350020A (zh) * 2015-09-24 2018-07-31 英特塞普特医药品公司 用于制备胆汁酸衍生物的方法和中间体
BR112018008936A2 (pt) * 2015-11-06 2018-11-27 Intercept Pharmaceuticals Inc métodos para a preparação de ácido obeticólico e derivados do mesmo
US20200262865A1 (en) * 2016-02-15 2020-08-20 Alexander Khoruts Compositions and methods for treating clostridium associated diseases
KR102377338B1 (ko) 2016-04-13 2022-03-21 인터셉트 파마슈티컬즈, 인크. 암의 치료 방법
TW201738254A (zh) * 2016-04-19 2017-11-01 英特賽普醫藥品公司 奧貝膽酸及其衍生物之製備方法
GB201608776D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Methods and compounds
GB201608777D0 (en) 2016-05-18 2016-06-29 Dextra Lab Ltd Compounds
CN109963567A (zh) * 2016-09-30 2019-07-02 英特塞普特医药品公司 胆汁酸衍生物的结晶形式
CA3070837A1 (en) 2017-07-24 2019-01-31 Intercept Pharmaceuticals, Inc. Isotopically labeled bile acid derivatives
JP7308811B2 (ja) * 2017-07-26 2023-07-14 チア タイ ティエンチン ファーマシューティカル グループ カンパニー リミテッド ステロイド系誘導体fxrアゴニストの製造方法
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
AU2020284135A1 (en) 2019-05-30 2022-01-06 Intercept Pharmaceuticals, Inc. Pharmaceutical compositions comprising a FXR agonist and a fibrate for use in the treatment of cholestatic liver disease
IL291985A (en) 2019-10-07 2022-06-01 Kallyope Inc Gpr119 agonists
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
UY39222A (es) 2020-05-19 2021-11-30 Kallyope Inc Activadores de la ampk
EP4172162A4 (en) 2020-06-26 2024-08-07 Kallyope, Inc. AMPK ACTIVATORS
EP4215540A4 (en) 2020-09-18 2025-01-15 Seoul National University R & DB Foundation METHOD FOR MASS PRODUCTION OF SODIUM TAURODEOXYCHOLATE

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5216015A (en) 1991-02-05 1993-06-01 Rhone-Poulenc Rorer Pharmaceuticals Inc. Compounds having hypocholesterolemic properties
DE60205891T2 (de) 2001-03-12 2006-06-22 Intercept Pharmaceuticals, Inc. Steroide als agonisten für fxr
EP1568706A1 (en) 2004-02-26 2005-08-31 Intercept Pharmaceuticals, Inc. Novel steroid agonist for FXR
EP2040713B1 (en) * 2006-06-27 2014-06-18 Intercept Pharmaceuticals Inc. Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions
WO2010036427A1 (en) * 2008-06-17 2010-04-01 Brigham Young University Cationic steroid antimicrobial diagnostic, detection, screening and imaging methods
AU2009276507B2 (en) * 2008-07-30 2015-11-19 Intercept Pharmaceuticals, Inc. TGR5 modulators and methods of use thereof
EP3150620B1 (en) * 2008-11-19 2020-01-08 Intercept Pharmaceuticals, Inc. Tgr5 modulators and methods of use thereof
US9777038B2 (en) 2012-10-26 2017-10-03 Intercept Pharmaceuticals, Inc. Process for preparing bile acid derivatives

Also Published As

Publication number Publication date
JP6272888B2 (ja) 2018-01-31
KR102068381B1 (ko) 2020-01-20
AU2013334122B2 (en) 2017-11-02
PL2912013T3 (pl) 2018-05-30
JP2015533852A (ja) 2015-11-26
NZ745013A (en) 2019-08-30
BR112015009395A2 (pt) 2017-07-04
CN108250264A (zh) 2018-07-06
CN105102425B (zh) 2018-04-10
MX361653B (es) 2018-12-13
ES2655034T3 (es) 2018-02-16
SG11201503247UA (en) 2015-06-29
CY1119731T1 (el) 2018-06-27
US9777038B2 (en) 2017-10-03
IL238454B (en) 2018-11-29
PT2912013T (pt) 2018-01-03
NZ707389A (en) 2018-08-31
WO2014066819A1 (en) 2014-05-01
KR20150074062A (ko) 2015-07-01
EP2912013A4 (en) 2016-06-01
AU2013334122A1 (en) 2015-05-14
SMT201700602T1 (it) 2018-03-08
NO2968302T3 (cg-RX-API-DMAC7.html) 2018-02-03
EP2912013A1 (en) 2015-09-02
HK1214239A1 (zh) 2016-07-22
HUE036887T2 (hu) 2018-08-28
HK1253301A1 (zh) 2019-06-14
EP2912013B1 (en) 2017-10-11
DK2912013T3 (en) 2018-01-15
US20180079776A1 (en) 2018-03-22
MX2015005286A (es) 2015-10-29
US10202414B2 (en) 2019-02-12
US20150291653A1 (en) 2015-10-15
CN105102425A (zh) 2015-11-25
IL238454A0 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
CA2889592A1 (en) Process for preparing bile acid derivatives
KR100555970B1 (ko) 2-아미노-1,3-프로판디올유도체의 제조방법
RU2624007C2 (ru) Способ получения улипристала ацетата и его промежуточных продуктов
US3822254A (en) Synthesis of 25-hydroxycholesterol
JP5717752B2 (ja) ピリピロペン誘導体の製造法
PL200165B1 (pl) Sposób wytwarzania estrów nitroksyalkilowych naproksenu oraz ester nitroksybutylowy kwasu 2-(S)-(6-metoksy-2-naftylo)propanowego o wysokim nadmiarze enancjomerycznym
PL130559B1 (en) Process for preparing pure isosorbite 5-nitrate
US3538120A (en) Cyclopentyl-alkanoic acids
CN110551133A (zh) 叔丁基-5-(羟甲基)-7-氧杂-2-氮杂螺[3.5]壬烷-2-甲酸基酯的制法
DK170233B1 (da) Fremgangsmåde til fremstilling af alkoxymethylether- og alkoxymethylesterderivater af glyceroler
EP0243646B1 (en) A process for the preparation of forskolin from 9-deoxy-forskolin and intermediates used therein
JP2024523040A (ja) ハイブチミブ中間体およびその調製法
AU2006272420A1 (en) Method for producing nebivolol
CN109134577B (zh) 一种3α-羟基-5α-胆烷酸的合成方法
US5072008A (en) Manufacture of lactol derivatives
PL243187B1 (pl) Sposób i związki pośrednie do otrzymywania menachinonu MK-7
HK1214239B (en) Process for preparing bile acid derivatives
US4906759A (en) Process for the production of 4-alkoxy-2(5H) thiophenones
Beccalli et al. 4-Azidotetronic Acids: A New Class of Azido Derivatives
JP2005314260A (ja) フラボンc配糖体の製法
CN101575287B (zh) 一种辛伐他汀铵盐的合成方法及所用中间体及其制备方法
Yamagata et al. Rhodium (II) acetate‐catalyzed reaction of 2‐amino‐4, 5‐dihydro‐3‐furancarbonitriles with dialkyl diazomalonates
Ye et al. Expedient Construction of the Ziegler Intermediate Useful for the Synthesis of Forskolin via Consecutive Rearrangements
JPH03246264A (ja) 2―アミノペンタン酸化合物の新規な製造法
CN102690254A (zh) 辛伐他汀铵盐中间体及其制备方法

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20180705

FZDE Discontinued

Effective date: 20220502

FZDE Discontinued

Effective date: 20220502